BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1324788)

  • 1. Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers.
    Zhang L; Nakaya K; Yoshida T; Kuroiwa Y
    Cancer Res; 1992 Sep; 52(17):4634-41. PubMed ID: 1324788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle arrest and protein kinase modulating effect of bufalin on human leukemia ML1 cells.
    Jing Y; Watabe M; Hashimoto S; Nakajo S; Nakaya K
    Anticancer Res; 1994; 14(3A):1193-8. PubMed ID: 8074471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
    Yamamoto-Yamaguchi Y; Makishima M; Kanatani Y; Kasukabe T; Honma Y
    Exp Hematol; 1996 May; 24(6):682-9. PubMed ID: 8635523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bufalin as a potent inducer of differentiation of human myeloid leukemia cells.
    Zhang LS; Nakaya K; Yoshida T; Kuroiwa Y
    Biochem Biophys Res Commun; 1991 Jul; 178(2):686-93. PubMed ID: 1859424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells.
    Liu Y; Chang RL; Cui XX; Newmark HL; Conney AH
    Oncol Res; 1997; 9(1):19-29. PubMed ID: 9112257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of combinations of transforming growth factor-beta 1 and tumor necrosis factor on induction of differentiation of human myelogenous leukemic cell lines.
    Kamijo R; Takeda K; Nagumo M; Konno K
    J Immunol; 1990 Feb; 144(4):1311-6. PubMed ID: 2105994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3.
    Miyaura C; Abe E; Suda T; Kuroki T
    Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of granulocyte-macrophage colony-stimulating factor in induction of monocytic differentiation of HL-60 cells: synergistic interaction with 1 alpha, 25-dihydroxyvitamin D3 and interferon-gamma in inducing interleukin-1 beta.
    Nakamaki T; Kawakami K; Sato S; Hino K; Tomoyasu S; Tsuruoka N; Honma Y; Hozumi M
    Anticancer Res; 1992; 12(5):1331-7. PubMed ID: 1444189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of Na+,K(+)-ATPase inhibition in K562 cell differentiation induced by bufalin.
    Numazawa S; Shinoki MA; Ito H; Yoshida T; Kuroiwa Y
    J Cell Physiol; 1994 Jul; 160(1):113-20. PubMed ID: 8021291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel role of vitamin K2: a potent inducer of differentiation of various human myeloid leukemia cell lines.
    Sakai I; Hashimoto S; Yoda M; Hida T; Ohsawa S; Nakajo S; Nakaya K
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1305-10. PubMed ID: 7802663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic regulatory effects of interleukin 6 and interleukin 1 on the growth and differentiation of human and mouse myeloid leukemic cell lines.
    Onozaki K; Akiyama Y; Okano A; Hirano T; Kishimoto T; Hashimoto T; Yoshizawa K; Taniyama T
    Cancer Res; 1989 Jul; 49(13):3602-7. PubMed ID: 2786454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of proliferating potential of myeloid leukemia cells during long-term treatment with vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: in vitro and in vivo studies.
    Kasukabe T; Honma Y; Hozumi M; Suda T; Nishii Y
    Cancer Res; 1987 Jan; 47(2):567-72. PubMed ID: 3466692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibition and differentiation in HL-60 leukemia cells induced by 1,25-dihydroxyvitamin D3 and tumor necrosis factor alpha.
    Wang SY; Chen LY; Wang SJ; Lin CK; Ho CK
    Exp Hematol; 1991 Nov; 19(10):1025-30. PubMed ID: 1915703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic suppression of the clonogenicity of U937 leukemic cells by combinations of recombinant human interleukin 4 and granulocyte colony-stimulating factor.
    Maekawa T; Sonoda Y; Kuzuyama Y; Inazawa J; Kimura S; Nakamichi K; Abe T
    Exp Hematol; 1992 Nov; 20(10):1201-7. PubMed ID: 1385197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
    Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation.
    Chen Q; DeFrances MC; Zarnegar R
    Cell Growth Differ; 1996 Jun; 7(6):821-32. PubMed ID: 8780895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
    Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
    Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of BCL-2 and bax protein in monocyte-mediated apoptosis in human leukemic cell lines.
    Legdeur MC; Bontje PM; Ossenkoppele GJ; Beelen RH; van de Loosdrecht AA; Broekhoven MG; Langenhuijsen MM; Thijsen SF; Hofstee H; Schuurhuis GJ
    Exp Hematol; 1996 Nov; 24(13):1530-9. PubMed ID: 8950237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta potentiates vitamin D3-induced terminal monocytic differentiation of human leukemic cell lines.
    Testa U; Masciulli R; Tritarelli E; Pustorino R; Mariani G; Martucci R; Barberi T; Camagna A; Valtieri M; Peschle C
    J Immunol; 1993 Mar; 150(6):2418-30. PubMed ID: 8383719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
    Breitman TR; He RY
    Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.